维普中文期刊产品整合服务
5篇 您的检索式:作者名="Martin Gaillard"
    题名 作者 年代 出处 被引量
1Laparoscopic liver resections for hepatocellular carcinoma:Current role and limitations显示文摘Liver resection for hepatocellular carcinoma(HCC)is currently known to be a safer procedure than it was before because of technical advances and improvement in postoperative patient management and remains the first-line treatment for HCC in compensated cirrhosis.The aim of this review is to assess current indications,advantages and limits of laparoscopic surgery for HCC resections.We also discussed the possible evolution of this surgical approach in parallel with new technologies.Martin Gaillard Hadrien Tranchart Ibrahim Dagher 2014World Journal of Gastroenterology2014,20,17:25
2New minimally invasive approaches for cholecystectomy: Review of literature显示文摘Laparoscopic cholecystectomy is the most commonlyperformed abdominal intervention in Western countries. In an attempt to reduce the invasiveness of the procedure, surgeons have developed single-incision laparoscopic cholecystectomy(SILC), minilaparoscopic cholecystectomy(MLC) and natural orifice transluminal endoscopic surgery(NOTES). The aim of this review was to determine the role of these new minimally invasive approaches for elective laparoscopic cholecystectomy in the treatment of gallstone related disease. Current literature remains insufficient for the correct assessment of emerging techniques for laparoscopic cholecystectomy. None of these procedures has demonstrated clear benefits over conventional laparoscopic cholecystectomy. SILC cannot be currently recommended as it can be associated with an increased risk of bile duct injury and incisional hernia incidence. NOTES cholecystectomy is still experimental, although hybrid transvaginal cholecystectomy is gaining popularity in clinical practice. As it is standardized and almost identical to the standard laparoscopic technique, MLC could lead to limited benefits without exposing patients to increased postoperative complications, being therefore adoptable for routine elective cholecystectomy. Technical challenges of SILC and NOTES cholecystectomy could be addressed with the evolution of new surgical tools that need to catch up with the innovative minds of surgeons. Regardless the place of these approaches in the future, robotization may be necessary to impose them as standard treatment.Martin Gaillard Hadrien Tranchart Panagiotis Lainas Ibrahim Dagher 2015World Journal of Gastrointestinal Surgery2015,7,10:5
3Lactate and acid-base balance in cord blood显示文摘Martin A Gaillard M Miot S 2003J Gynecol Obstet Biol Reprod (Paris)2003,32,81:1
4A phase II evaluation of AMG 102 (rilotumumab) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: A Gynecologic Oncology Group study显示文摘Lainie P. Martin Michael Sill Mark S. Shahin Matthew Powell Paul DiSilvestro Lisa M. Landrum Stephanie L. Gaillard Michael J. Goodheart James Hoffman Russell J. Schilder 2013Gynecologic Oncology2013,,:1
5Current strategies to induce liver remnant hypertrophy before major liver resection显示文摘Hepatic resection is the gold standard for patients affected by primary or metastatic liver tumors but is hampered by the risk of post-hepatectomy liver failure.Despite recent impro-vements,liver surgery still requires excellent clinical judgement in selecting patients for surgery and,above all,efficient pre-operative strategies to provide adequate future liver remnant.The aim of this article is to review the literature on the rational,the preliminary assessment,the advantages as well as the limits of each existing technique for preparing the liver for major hepatectomy.Celeste Del Basso Martin Gaillard Panagiotis Lainas Stella Zervaki Gabriel Perlemuter Pierre Chagué Laurence Rocher Cosmin Sebastian Voican Ibrahim Dagher Hadrien Tranchart 2021World Journal of Hepatology2021,13,11:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费